Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Nutrition & Food Science
  4. Fast Track Articles
  5. Fast Track Article
image of Efficacy and Safety of a Unani Pharmacopeial Powder Formulation and Sharbat Banafsha in Women with Uncomplicated Urinary Tract Infection: A Pilot Self-Control Clinical Trial

Abstract

Background

Antimicrobial resistance is a growing global concern, highlighting the urgent need for effective non-antibiotic alternatives to treat urinary tract infections. Effortlessly blending traditional Unani knowledge with modern scientific evaluation, this study highlights the potential of Unani formulations in managing uncomplicated UTIs. This study's findings underscore the importance of exploring and bridging the gap between Unani medicine and evidence-based practices. This study investigates the efficacy and safety of an Unani Pharmacopeial powder formulation and in treating women with uncomplicated urinary tract infections (UTI).

Materials and Methods

The pre and post-test pilot self-control clinical study involved 13 participants with uUTI who received 3.5 g powder Unani formulation comprising (Molina) Standl, L., L. and L., L., and L. with (syrup of L.) 25 ml twice daily for 8 days. The primary outcomes were assessed using the urinary tract infection symptoms assessment (UTISA) questionnaire, while secondary outcomes included urine culture and sensitivity, as well as health-related quality of life (HRQoL) assessment using the SF-12 health survey. The data was analyzed, and <0.05 was considered significant.

Results

The UTISA total score from 15.69±2.18 was reduced to 4.00±5.07 on day 9 with a significance difference(<0.001). On day 14, 84.61% of the population had negative cultures. The total SF-12, PCS, and MCS scores showed significant differences from Day 0 to 60 (>0.05). No adverse effects were reported in both groups. HPLC analysis confirmed the presence of the plant metabolite luteolin in both the powder and syrup.

Conclusion

The data explores the effectiveness of Unani formulations for bacterial urinary tract infections (UTI), showing no adverse effects while also improving the HRQoL of women. These herbal products contain luteolin, a bioactive molecule with antimicrobial properties.

Clinical Trial Registration Number

CTRI/2020/02/023404 dated 17/02/2020.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnf/10.2174/0115734013319264241031105823
2024-11-05
2025-01-18

  • From This Site

    /content/journals/cnf/10.2174/0115734013319264241031105823
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Anju P.C. A study to evaluate the efficacy of cranberry extract supplements in prevention of recurrent urinary tract infections in female patients. Int. J. Basic Clin. Pharmacol. 2020 9 1854 10.18203/2319‑2003.ijbcp20205122
    [Google Scholar]
  2. Murugesu S. Selamat J. Perumal V. Phytochemistry, pharmacological properties, and recent applications of Ficus benghalensis and Ficus religiosa. Plants 2021 10 12 2749 10.3390/plants10122749 34961220
    [Google Scholar]
  3. Pandey D. Khanam Z. Urinary tract infections in pregnancy. Infect Pregnancy. Singapore Springer 2022 367 381 10.1007/978‑981‑16‑7865‑3_24
    [Google Scholar]
  4. Gama C.R.B. Pombo M.A.G. Nunes C.P. Treatment of recurrent urinary tract infection symptoms with urinary antiseptics containing methenamine and methylene blue: Analysis of etiology and treatment outcomes. Res. Rep. Urol. 2020 12 639 649 10.2147/RRU.S279060 33365282
    [Google Scholar]
  5. Gágyor I. Hummers E. Schmiemann G. Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: A randomized controlled trial. Clin. Microbiol. Infect. 2021 27 10 1441 1447 10.1016/j.cmi.2021.05.032 34111592
    [Google Scholar]
  6. Dason S. Dason J.T. Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can. Urol. Assoc. J. 2013 5 5 316 322 10.5489/cuaj.687 22031610
    [Google Scholar]
  7. Rahman S.R. Ahmed M.F. Begum A. Occurrence of urinary tract infection in adolescent and adult women of shanty town in Dhaka City, Bangladesh. Ethiop. J. Health Sci. 2014 24 2 145 152 10.4314/ejhs.v24i2.7 24795516
    [Google Scholar]
  8. George C. Norman G. Ramana G.V. Mukherjee D. Rao T. Treatment of uncomplicated symptomatic urinary tract infections: Resistance patterns and misuse of antibiotics. J. Family Med. Prim. Care 2015 4 3 416 421 10.4103/2249‑4863.161342 26288784
    [Google Scholar]
  9. Chang S.J. Lin C.D. Hsieh C.H. Liu Y.B. Chiang I.N. Yang S.S.D. Reliability and validity of a chinese version of urinary tract infection symptom assessment questionnaire. Int. Braz J Urol 2015 41 4 729 738 10.1590/S1677‑5538.IBJU.2014.0046 26401866
    [Google Scholar]
  10. Gágyor I. Rentzsch K. Strube-Plaschke S. Himmel W. Psychometric properties of a self-assessment questionnaire concerning symptoms and impairment in urinary tract infections: The UTI-SIQ-8. BMJ Open 2021 11 2 e043328 10.1136/bmjopen‑2020‑043328 33589460
    [Google Scholar]
  11. Raz R. Urinary tract infection in postmenopausal women. Korean J. Urol. 2011 52 12 801 808 10.4111/kju.2011.52.12.801 22216390
    [Google Scholar]
  12. Car J. Urinary tract infections in women: Diagnosis and management in primary care. BMJ 2006 332 7533 94 97 10.1136/bmj.332.7533.94 16410583
    [Google Scholar]
  13. Khan AH Karachi Madina Publication 1983
  14. Khan A. Iksir-i-A’zam. New Delhi Idarae Kitabus Shifa 2011
    [Google Scholar]
  15. Qamri M. Ghina Muna. Markazi Council Bara Tahiqeqate Tib Unani. New Delhi Nizami Press 2008
    [Google Scholar]
  16. Flower A. Wang L.Q. Lewith G. Liu J.P. Li Q. Chinese herbal medicine for treating recurrent urinary tract infections in women. Cochrane Libr. 2015 2017 6 CD010446 10.1002/14651858.CD010446.pub2 26040964
    [Google Scholar]
  17. Vahlensieck W. Lorenz H. Schumacher-Stimpfl A. Fischer R. Naber K. Effect of a herbal therapy on clinical symptoms of acute lower uncomplicated urinary tract infections in women: Secondary analysis from a randomized controlled trial. Antibiotics 2019 8 4 256 10.3390/antibiotics8040256 31817885
    [Google Scholar]
  18. Brown E.D. Wright G.D. Antibacterial drug discovery in the resistance era. Nature 2016 529 7586 336 343 26791724
    [Google Scholar]
  19. Chandra H. Bishnoi P. Yadav A. Patni B. Mishra A. Nautiyal A. Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials - A review. Plants 2017 6 2 16 10.3390/plants6020016 28394295
    [Google Scholar]
  20. Sachan A.K. Das D.R. Kumar M. Carum carvi-an important medicinal plant. J. Chem. Pharm. Res. 2016 8 529 533
    [Google Scholar]
  21. Anand U. Jacobo-Herrera N. Altemimi A. Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: Potential avenues of biocompatible drug discovery. Metabolites 2019 9 11 258 10.3390/metabo9110258 31683833
    [Google Scholar]
  22. Manandhar S. Luitel S. Dahal R.K. In vitro antimicrobial activity of some medicinal plants against human pathogenic bacteria. J. Trop. Med. 2019 2019 1895340 10.1155/2019/1895340
    [Google Scholar]
  23. Afzal S. Ahmad H.I. Jabbar A. Use of medicinal plants for respiratory diseases in Bahawalpur, Pakistan. BioMed Res. Int. 2021 2021 1 5578914 10.1155/2021/5578914 33884265
    [Google Scholar]
  24. Sharma A. Chandraker S. Patel V.K. Ramteke P. Antibacterial activity of medicinal plants against pathogens causing complicated urinary tract infections. Indian J. Pharm. Sci. 2009 71 2 136 139 10.4103/0250‑474X.54279 20336211
    [Google Scholar]
  25. Arzani A. Qarabadeen Qadri. New Delhi I’jaz Publishing House 2009
    [Google Scholar]
  26. Ghani N. Khazainul Advia. New Delhi Idarae Kitabus Shifa 2001
    [Google Scholar]
  27. Zaatout H AlShaikh N Sallam S Hammoda H Phytochemical and biological activities of lagenaria siceraria: An overview. Egypt J Chem 2023 0 0 0 10.21608/ejchem.2023.182665.7373
    [Google Scholar]
  28. Habte G. Tamiru S. Eyasu K. In vivo antimalarial activity of the 80% methanolic crude fruit extract of Lagenaria siceraria (Molina) Standl. against Plasmodium berghei infected mice. Heliyon 2023 9 4 e15453 10.1016/j.heliyon.2023.e15453 37151678
    [Google Scholar]
  29. Batiha G.E.S. Tene S.T. Teibo J.O. The phytochemical profiling, pharmacological activities, and safety of malva sylvestris: A review. Naunyn Schmiedebergs Arch. Pharmacol. 2023 396 3 421 440 10.1007/s00210‑022‑02329‑w 36418467
    [Google Scholar]
  30. Revathi B. Sasidhar B. Babu G.R. Divyalatha J. Devadasu C. Dhachinamoorthi D. Evaluation of antibacterial activity of aqueous extract of Cucumis melo. RJPP 2023 15 1 1 4 10.52711/0975‑4385.2023.00001
    [Google Scholar]
  31. Ismail A.M. Flavonoid contents of adiantum capillus-veneris L. growing in two different districts from iraqi Kurdistan Northern Iraq. Egypt. Acad. J. Biol. Sci. H Bot. 2017 8 1 25 31 10.21608/eajbsh.2017.16815
    [Google Scholar]
  32. Zhou Y.X. Xin H.L. Rahman K. Wang S.J. Peng C. Zhang H. Portulaca oleracea L.: A review of phytochemistry and pharmacological effects. BioMed Res. Int. 2015 2015 1 11 10.1155/2015/925631 25692148
    [Google Scholar]
  33. Khare C.P. Indian medicinal plants: An illustrated dictionary. New Delhi Springer Berlin Heidelberg 2007 10.1007/978‑0‑387‑70638‑2
    [Google Scholar]
  34. Clayson D. Wild D. Doll H. Keating K. Gondek K. Validation of a patient‐administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): The UTI Symptom Assessment questionnaire. BJU Int. 2005 96 3 350 359 10.1111/j.1464‑410X.2005.05630.x 16042729
    [Google Scholar]
  35. Soh S.E. Morello R. Ayton D. Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: A Rasch analysis. Health Qual. Life Outcomes 2021 19 1 157 10.1186/s12955‑021‑01794‑w 34059079
    [Google Scholar]
  36. Kontiokari T. Sundqvist K. Nuutinen M. Pokka T. Koskela M. Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in. BMJ 2001 322 7302 1571 10.1136/bmj.322.7302.1571 11431298
    [Google Scholar]
  37. Wahid M. Saqib F. Akhtar S. Ali A. Tallei T.E. Simal-Gandara J. Mechanistic insights of Cucumis melo L. seeds for gastrointestinal muscle spasms through calcium signaling pathway–related gene regulation networks in WGCNA and in vitro, in vivo studies. Comput. Biol. Med. 2023 155 106596 10.1016/j.compbiomed.2023.106596 36773554
    [Google Scholar]
  38. López-Lázaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev. Med. Chem. 2009 9 1 31 59 10.2174/138955709787001712 19149659
    [Google Scholar]
  39. Terninko II Onishchenko UE Frolova A Phenolic compounds Malva sylvestris by high performance liquid chromatography. PHARMA Innov- J Res 2014 2014 3 46 50
    [Google Scholar]
  40. Karioti A. Furlan C. Vincieri F.F. Bilia A.R. Analysis of the constituents and quality control of Viola odorata aqueous preparations by HPLC-DAD and HPLC-ESI-MS. Anal. Bioanal. Chem. 2011 399 4 1715 1723 10.1007/s00216‑010‑4473‑2 21153584
    [Google Scholar]
  41. Arsene MMJ Viktorovna PI Davares AKL Esther N Nikolaevich SA Urinary tract infections: Virulence factors, resistance to antibiotics, and management of uropathogenic bacteria with medicinal plants—A review. J Appl Pharm Sci 2021 11 001 012 10.7324/JAPS.2021.110701
    [Google Scholar]
  42. Qian W. Liu M. Fu Y. Antimicrobial mechanism of luteolin against Staphylococcus aureus and Listeria monocytogenes and its antibiofilm properties. Microb. Pathog. 2020 142 104056 10.1016/j.micpath.2020.104056 32058023
    [Google Scholar]
  43. Insanu M. Rizaldy D. Silviani V. Fidrianny I. Chemical compounds and pharmacological activities of cucumis genus. Biointerface Res. Appl. Chem. 2021 12 1 1324 1334 10.33263/BRIAC121.13241334
    [Google Scholar]
  44. Kashari O. Antibacterial activity and phytochemical screening of calabash seed oil on clinical isolates from skin. Int J Adv Acad Res 2018 4 2488 9849
    [Google Scholar]
  45. Tleubayeva M.I. Datkhayev U.M. Alimzhanova M. Component composition and antimicrobial activity of CO2 extract of Portulaca oleracea, growing in the territory of Kazakhstan. Sci World J 2021 2021 1 10 10.1155/2021/5434525 33551685
    [Google Scholar]
  46. Lei X. Li J. Liu B. Zhang N. Liu H. Separation and identification of four new compounds with antibacterial activity from portulaca oleracea L. Molecules 2015 20 9 16375 16387 10.3390/molecules200916375 26378504
    [Google Scholar]
  47. Sultana A. Rahman K. Portulaca oleracea Linn: A global panacea with ethnomedicinal and pharmacological potential. Int. J. Pharm. Pharm. Sci. 2013 5 33 39
    [Google Scholar]
  48. Insanu M. Karimah H. Pramastya H. Fidrianny I. Phytochemical compounds and pharmacological activities of vitis vinifera L.: An updated review. Biointerface Res. Appl. Chem. 2021 11 6 13829 13849 10.33263/BRIAC115.1382913849
    [Google Scholar]
  49. Al Akeel R. Mateen A. Alharbi K.K. Alyousef A.A. Al-Mandeel H.M. Syed R. Purification and MIC analysis of antimicrobial proteins from Cucumis sativus L. seeds. BMC Complement. Altern. Med. 2018 18 1 121 10.1186/s12906‑018‑2176‑y 29615020
    [Google Scholar]
  50. Yunusa A.K. Dandago M.A. Ibrahim S.M. Abdullahi N. Rilwan A. Barde A. Total phenolic content and antioxidant capacity of different parts of cucumber (Cucumis Sativus L.). Acta Univ. Cibiniensis Ser. E Food Technol. 2018 22 2 13 20 10.2478/aucft‑2018‑0008
    [Google Scholar]
  51. Ishaq M.S. Hussain M.M. Siddique Afridi M. In vitro phytochemical, antibacterial, and antifungal activities of leaf, stem, and root extracts of Adiantum capillus veneris. ScientificWorldJournal 2014 2014 1 7 10.1155/2014/269793 24592156
    [Google Scholar]
  52. Mahboubi A. Kamalinejad M. Ayatollahi A.M. Babaeian M. Total phenolic content and antibacterial activity of five plants of labiatae against four foodborne and some other bacteria. Iran. J. Pharm. Res. 2014 13 2 559 566 25237351
    [Google Scholar]
  53. Gautam S.S. Navneet, Kumar S. The antibacterial and phytochemical aspects of Viola odorata Linn. Extracts against respiratory tract pathogens. Proc. Natl. Acad. Sci., India, Sect. B Biol. Sci. 2012 82 4 567 572 10.1007/s40011‑012‑0064‑7
    [Google Scholar]
  54. Ahmed A. Jahan N. Wadud A. Imam H. Hajera S. Bilal A. Physicochemical and biological properties of adiantum capillus- veneris linn: An important drug of unani system of medicine. Int J Pharm Res 2012 4 70 75
    [Google Scholar]
  55. Inanmdar W. Sultana A. Mubeen U. Rahman K. Clinical efficacy of Trigonella foenum graecum (Fenugreek) and dry cupping therapy on intensity of pain in patients with primary dysmenorrhea. Chin. J. Integr. Med. 2016 2016 1 8 10.1007/s11655‑016‑2259‑x 27225291
    [Google Scholar]
  56. Visuvanathan T. Than L.T.L. Stanslas J. Chew S.Y. Vellasamy S. Revisiting Trigonella foenum-graecum L.: Pharmacology and therapeutic potentialities. Plants 2022 11 11 1450 10.3390/plants11111450 35684222
    [Google Scholar]
  57. Singh A. Dhariwal S. Navneet D. Traditional uses, antimicrobial potential, pharmacological properties and phytochemistry of viola odorata: A mini review. Journal of Phytopharmacology 2018 7 1 103 105 10.31254/phyto.2018.7120
    [Google Scholar]
  58. Katoch M. Singh A. Singh G. Wazir P. Kumar R. Phylogeny, antimicrobial, antioxidant and enzyme-producing potential of fungal endophytes found in Viola odorata. Ann. Microbiol. 2017 67 8 529 540 10.1007/s13213‑017‑1283‑1
    [Google Scholar]
  59. Payez A.P. Deldadeh N. Ghiasvand S.G. Evaluation and comparison of antimicrobial and anticancer effects of aqueous and ethanolic extracts of viola odorata. Multidisciplinary Cancer Investigation 2022 6 3 1 6 10.30699/mci.6.3.607‑1
    [Google Scholar]
  60. Mulla İ. Roqaiya M. Imran Khan M. Efficacy of Viola odorata flower decoction in chronic rhinosinusitis. Medical Journal of Islamic World Academy of Sciences 2019 27 3 77 84 10.5505/ias.2019.08379
    [Google Scholar]
  61. Saeedi R. Sultana A. Rahman K. Ethnomedicinal uses nad pharmacological activities of different parts of Cucumus sativus linn: An update. Int. J. Pharm. Sci. Res. 2020 11 4 1549 1556 10.13040/IJPSR.0975‑8232.11(4).1549‑56
    [Google Scholar]
  62. Schmiemann G. Kniehl E. Gebhardt K. Matejczyk M.M. Hummers-Pradier E. The diagnosis of urinary tract infection: A systematic review. Dtsch. Arztebl. Int. 2010 107 21 361 367 10.3238/arztebl.2010.0361
    [Google Scholar]
/content/journals/cnf/10.2174/0115734013319264241031105823
Loading
Efficacy and Safety of a Unani Pharmacopeial Powder Formulation and Sharbat Banafsha in Women with Uncomplicated Urinary Tract Infection: A Pilot Self-Control Clinical Trial
Bentham Science Publishers ; https://doi.org/10.2174/0115734013319264241031105823
/content/journals/cnf/10.2174/0115734013319264241031105823
/content/journals/cnf/10.2174/0115734013319264241031105823
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Health-related quality of life ; uncomplicated urinary tract infection (UTI) ; Female diseases ; UTISA questionnaire ; Unani Medicine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test